Ariane Dienst

707 total citations
18 papers, 291 citations indexed

About

Ariane Dienst is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Ariane Dienst has authored 18 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Ariane Dienst's work include Acute Myeloid Leukemia Research (9 papers), Multiple Myeloma Research and Treatments (6 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Ariane Dienst is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Multiple Myeloma Research and Treatments (6 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Ariane Dienst collaborates with scholars based in Germany, United States and Switzerland. Ariane Dienst's co-authors include Rainer Haas, Guido Kobbe, Jochen W.U. Fries, Claudia Gottstein, Kathrin Nachtkamp, Andrea Grunow, Roland Fenk, Ulrich Germing, Jacques E. Nör and Mustafa Kondakci and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Ariane Dienst

18 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ariane Dienst Germany 8 202 136 57 44 40 18 291
Anna E. Marneth United States 10 113 0.6× 132 1.0× 76 1.3× 13 0.3× 26 0.7× 21 275
Ernest A. McCulloch Canada 8 117 0.6× 117 0.9× 56 1.0× 29 0.7× 54 1.4× 13 290
Hye Na Kim United States 8 107 0.5× 119 0.9× 36 0.6× 94 2.1× 75 1.9× 20 307
Maja Rothenberg‐Thurley Germany 10 347 1.7× 205 1.5× 111 1.9× 61 1.4× 41 1.0× 27 423
Adriana da Silva Santos Duarte Brazil 12 78 0.4× 167 1.2× 61 1.1× 8 0.2× 45 1.1× 27 306
Kyi Min Saw Canada 7 151 0.7× 77 0.6× 101 1.8× 16 0.4× 34 0.8× 10 282
Tim Grob Netherlands 7 309 1.5× 190 1.4× 98 1.7× 49 1.1× 39 1.0× 18 423
Phillip M. Clair United States 7 81 0.4× 141 1.0× 70 1.2× 7 0.2× 65 1.6× 13 256
A.Yu. Zaritskey Russia 3 191 0.9× 153 1.1× 89 1.6× 20 0.5× 89 2.2× 6 329
Cintia Carella Italy 7 92 0.5× 132 1.0× 31 0.5× 16 0.4× 108 2.7× 9 271

Countries citing papers authored by Ariane Dienst

Since Specialization
Citations

This map shows the geographic impact of Ariane Dienst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariane Dienst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariane Dienst more than expected).

Fields of papers citing papers by Ariane Dienst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariane Dienst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariane Dienst. The network helps show where Ariane Dienst may publish in the future.

Co-authorship network of co-authors of Ariane Dienst

This figure shows the co-authorship network connecting the top 25 collaborators of Ariane Dienst. A scholar is included among the top collaborators of Ariane Dienst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariane Dienst. Ariane Dienst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Fenk, Roland, Aristoteles Giagounidis, Hartmut Goldschmidt, et al.. (2020). Efficacy and Tolerability of High- versus Low-dose Lenalidomide Maintenance Therapy of Multiple Myeloma after Autologous Blood Stem Cell Transplantation. Clinical Cancer Research. 26(22). 5879–5886. 4 indexed citations
2.
Schuler, Esther, Christina Rautenberg, Kathrin Nachtkamp, et al.. (2019). Relapse patterns and treatment strategies in patients receiving allogeneic hematopoietic stem cell transplantation for myeloid malignancies. Annals of Hematology. 98(5). 1225–1235. 19 indexed citations
3.
4.
Fenk, Roland, Aristoteles Giagounidis, Hartmut Goldschmidt, et al.. (2018). Maintenance therapy (MT) with 25 versus 5 mg lenalidomide (Len) after prolonged Len consolidation therapy (CT) in newly-diagnosed, transplant-eligible patients (pts) with multiple myeloma (MM).. Journal of Clinical Oncology. 36(15_suppl). 8016–8016. 1 indexed citations
5.
6.
Giagounidis, Aristoteles, Hartmut Goldschmidt, Michael Heinsch, et al.. (2018). Similar Quality of Life with 5mg Versus 25mg Lenalidomide Maintenance after First-Line High-Dose Therapy and Autologous Blood Stem Cell Transplantation for Multiple Myeloma: Results of the Lenamain Trial. Blood. 132(Supplement 1). 2003–2003. 2 indexed citations
7.
8.
Wilk, C. Matthias, Ron‐Patrick Cadeddu, Ariane Dienst, et al.. (2016). Lenalidomide consolidation treatment in patients with multiple myeloma suppresses myelopoieses but spares erythropoiesis. International Journal of Cancer. 139(10). 2343–2352. 1 indexed citations
9.
10.
Rautenberg, Christina, Kathrin Nachtkamp, Ariane Dienst, et al.. (2016). Sorafenib and azacitidine as salvage therapy for relapse of FLT3‐ITD mutated AML after allo‐SCT. European Journal Of Haematology. 98(4). 348–354. 36 indexed citations
11.
Schroeder, Thomas, Julia Fröbel, Ron‐Patrick Cadeddu, et al.. (2012). Salvage Therapy with Azacitidine Increases Regulatory T Cells in Patients with AML or MDS and Early Relapse After Allogeneic Blood Stem Cell Transplantation. Blood. 120(21). 1964–1964. 1 indexed citations
12.
Kuendgen, A., Thomas Schroeder, Ariane Dienst, et al.. (2011). 93 Analysis of treatment choices and outcome for MDS and AML patients 60 years and older from the university of Dusseldorf. Leukemia Research. 35. S35–S35. 1 indexed citations
13.
Kuendgen, A., Gesine Bug, Oliver G. Ottmann, et al.. (2011). Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid. Clinical Epigenetics. 2(2). 389–399. 29 indexed citations
14.
Czibere, Akos, Ingmar Bruns, Roland Fenk, et al.. (2008). Sorafenib (Nexavar®) induces molecular remission and regression of extramedullary disease in a patient with FLT3-ITD+ acute myeloid leukemia. Leukemia Research. 33(2). 348–350. 63 indexed citations
15.
Kuendgen, A., Gesine Bug, Oliver G. Ottmann, et al.. (2008). Treatment of Poor Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia with a Combination of 5-Azacytidine and Valproic Acid. Blood. 112(11). 3639–3639. 8 indexed citations
16.
17.
Dienst, Ariane, et al.. (2005). Specific Occlusion of Murine and Human Tumor Vasculature by VCAM-1–Targeted Recombinant Fusion Proteins. JNCI Journal of the National Cancer Institute. 97(10). 733–747. 67 indexed citations
18.
Dienst, Ariane, et al.. (2003). Soluble Tissue Factor Induces Coagulation on Tumor Endothelial Cells In Vivo if Coadministered With Low-Dose Lipopolysaccharides. Arteriosclerosis Thrombosis and Vascular Biology. 23(5). 905–910. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna E. Marneth Breakdown of academic impact, for papers by Ernest A. McCulloch Breakdown of academic impact, for papers by Hye Na Kim Breakdown of academic impact, for papers by Maja Rothenberg‐Thurley Breakdown of academic impact, for papers by Adriana da Silva Santos Duarte Breakdown of academic impact, for papers by Kyi Min Saw Breakdown of academic impact, for papers by Tim Grob Breakdown of academic impact, for papers by Phillip M. Clair Breakdown of academic impact, for papers by A.Yu. Zaritskey Breakdown of academic impact, for papers by Cintia Carella
Rankless by CCL
2026